No watchlist name moved 3% today. The story is Meta’s financing, which sets up dilution risk just as earnings week gets going.
Company news worth knowing#
- META — $620.19, −1.64% | priced a $25B Class A forward sale at $625 plus a $12.5B 6.50% mandatory convertible preferred, part of an AI-capex equity plan upsized to roughly $97.5B (pricing term sheet) | Hold (medium): forward-sale proceeds arrive gradually through Nov 2027, so the dilution is spread out, and the raise adds an overhang to a stock already down after last week’s capex-driven drop
Quiet: AMZN +1.6%, MSFT −0.2%, NET −1.2%, RDDT −1.4%.
Earnings: MSFT Oct 28; AMZN and RDDT Oct 29; NET Nov 5.